Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
Classic infantile Pompe disease (IPD) is a rare lysosomal storage disorder characterized by severe hypertrophic cardiomyopathy and profound muscle weakness. Without treatment, death occurs within the first 2 years of life. Although enzyme replacement therapy (ERT) with alglucosidase alfa has improve...
Guardado en:
Autores principales: | Javier de las Heras, Ainara Cano, Ana Vinuesa, Marta Montes, María Unceta Suarez, Arantza Arza, Saioa Jiménez, Elena Vera, Marta del Hoyo, Miriam Gendive, Lizar Aguirre, Gisela Muñoz, Javier Fernández, Cynthia Ruiz-Espinoza, María Ángeles Fernández, José Miguel Galdeano, Irene Rodríguez, Lourdes Román, Amaya Rodríguez-Serna, Begoña Loureiro, Itziar Astigarraga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05147c9eb1a64757918d5361ca6ff5e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Alícia Dorneles Dornelles, et al.
Publicado: (2021) -
Molecular study of Pompe disease in Egyptian infants
por: Mona Essawi, et al.
Publicado: (2021) -
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Antonietta Tarallo, et al.
Publicado: (2021) -
Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
por: Paweł Robak, et al.
Publicado: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
por: Zhang B, et al.
Publicado: (2016)